35P Toxicity and safety of novel immuno-oncology (IO) treatments after prior immune checkpoint inhibitors (ICIs) exposure

Authors :: E. Muñoz Couselo
Analia Azaro
A. Valdivia
Alberto Hernando
Elena Garralda
R. Berché
L. Fariñas Madrid
R. Dienstmann
Irene Brana
P. Iranzo Gomez
R. Morales Barrera
N. Mulet Margalef
Vladimir Galvao
H.K. Oberoi Oberoi
J. Tabernero
O. Saavedra
M. Vieito Villar
Guzman Alonso
Natassia Ann Wornham
I. Matos Garcia
Source :: Annals of Oncology. 31:S1430
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Immune checkpoint inhibitors
Toxicity
Medicine
Hematology
business

Full Text Access

Tools